member login

Training programme

 


 

VacTrain offers network-wide training activities, including VacTrain conferences, training courses, transferable skills courses, e-learning modules, and secondments to other host institutes or associated partners. These training elements of the VacTrain programme will provide the tools to become complete vaccinologists with knowledge of all phases and sectors involved in the value chain of vaccine development.

 

VacTrainees at Kick-off consortium meeting in Oxford

 

VacTrain conferences
 

VacTrain consortium meeting 1 – Oxford, UK – 22-23 November 2013
VacTrain consortium meeting 2 – Leiden, the Netherlands – 3-5 September 2014
VacTrain consortium meeting 3 – Berlin, Germany – 13-14 October 2015
VacTrain consortium meeting 4 – Leiden, the Netherlands – 11-12 May 2016

 

 

 


 

Training courses
 

Human and Veterinary Vaccinology – Oxford, UK – 18-22 November 2013
Kick-off meeting OxfordThis 5-days course includes contributions from 18 world-leading experts and will provide an overview of the immune system, recent advances in human and veterinary vaccinology and the impact of molecular immunology. Also, the vaccine development pathway, pre-clinical testing, and ethical issues will be discussed.
 

Introduction to Regulatory Affairs – Dorking, UK – 31 March-4 April 2014
This 5-days course discusses the role and importance of the regulatory affairs function and how it fits into the product development process. It also addresses the EU regulatory environment, the organisations involved and how legislation is developed. In addition, it shows the importance of Good Manufacturing Practice and Good Clinical Practice.

 

The Future of Vaccinology (incl. pharmacoeconomics) – Leiden, the Netherlands – 8-12 September 2014
This 5-days workshop will give an overview of the whole process of vaccine development, from the initial idea, the development and production, until the use of vaccines in practice. Special attention will also be given to pharmacoeconomics and the role of vaccinations in public health especially compared to other health interventions.

 

Clinical Vaccine Development and Vaccine Biomanufacturing – Oxford, UK – 20-23 October 2015
This course gives an overview of the pathway from pre-clinical vaccine testing to Phase I to IV clinical trials. It discusses vaccine immunogenicity and the need for correlates of immune protection. In addition, an overview of the biomanufacturing processes, vaccine markets and growth drives for developed and developing settings is provided. This course includes an introduction to the principles of Good Clinical Practice, Good Manufacturing Practice and Quality Assurance. 

 

Masterclass VacTrain - Leiden, the Netherlands  9-10 May 2016

This Masterclass will provide its attendees not only state-of-the-art scientific lectures on the current innovations in the vaccine world, but will also provide the opportunity to meet the most interesting players in the vaccine job market to talk about future career opportunities. Lectures will be given by representatives of the EU vaccine consortia VacTrain, ADITEC, TBVAC2020 and ZAPI (FP7, H2020 and IMI). The Masterclass will be open to those interested in vaccine development.  

 


 

Transferable skill courses

Provided by ALTA - 11-15 April 2016
 

Guest Lecture Oxford

Science communication (1 day)

This course aims to improve scientific writing (research articles, project applications), presentation skills (scientific meetings, interaction with the press and the public at large) and communication (within pharmaceutical companies).
 

Legal skills and IPR (1 day)
This course discusses protective strategies during research and development (patents and intellectual property) and "security" policies, with a focus on protection and implementation within a pharmaceutical company.
 

Project management (1 day)
This course addresses issues encountered in daily jobs as project managers. It deals with issues such as leadership, collaboration, negotiation, commitment and efficiency within your own project, but also within multilocation projects.
 

Grant writing (2 days)
This 2-day course briefly presents the world of funding agencies (with a special attention to the EC and Horizon 2020) and addresses grant applications from the scientific, technical and financial sides, providing several tips to the attendees. The course ends with a practical exercise on a grant proposal.
 


 

E-learning
 

Electronic or web-based learning creates unique learning experiences for our VacTrainees. The Health Science eTraining (HSeT) Foundation have developed protocol-based and case-based e-learning modules on immunology, microbiology and vaccinology, which complement the other training activities of VacTrain. The e-learning modules ‘Good Clinical Practice’ and ‘Influenza vaccines’ have to be completed by all VacTrainees before the end of their contract. The progress of the VacTrainees can be monitored and the content of the modules will be updated regularly.



 

Secondments
 

Fellow (institute) Place of Secondment Purpose
Mariateresa Coppola (LUMC)                 Germans Trias i Pujol Research Institute, Barcelona, Spain                   

Validate the immunogenicity of newly selected candidate Mtb IVE-TB antigens in a large cohort of TB patients using ELISA, Luminex and FACS analyses.

Eleni Panagioti (LUMC) University College London (UCL), London, UK Test the immunoreactivity of HCMV IE2 peptide epitopes in CMV seropositive samples, and learn B cell detection assays.
Roberta Rovita (LUMC) Max Planck Institute (MPG), Berlin, Germany Use NGS to get knowledge in cytokine gene expression profile on dried-blood-spots of CMV infected children and non-infected children.
Benedict Halbroth (OXU) Vakzine Project Management (VPM), Hannover, Germany Gain detailed understanding of project management in vaccine research (vaccine development, valuation & evaluation of projects, regulatory interactions, quality management, etc).
Claudia Lindemann (OXU) GSK Vaccines (GSK), Siena, Italy (i) Using in vivo bacterial transcriptome analysis to identify vaccine escape mechanisms using Novartis’ vaccine candidates; (ii) MRI/histology of infected kidneys; (iii) Challenging vaccinated mice with human clinical isolates
Ioanna Christopoulou (VIB) Icahn School of Medicine at Mount Sinai, New York, USA Investigate immunological responses to influenza/ co-infection.
Esther Oiknine-Djian (HUH) Hebrew University of Jerusalem, Jerusalem, Israel Acquire expertise in the field of Bio-informatics (especially, viral genome and viral/cellular transcriptome analysis).
Ilona Baraniak (UCL)

Vakzine Project Management (VPM), Hannover, Germany

Gain experience in R&D and project management (development of promising biopharmaceuticals candidates, creation of business strategies).
Praneeth Reddy Devulapally (MPG) DRDx (Drug Response Dx) GmbH, Berlin, Germany Deepen my understanding and knowledge with generation of monoclonal antibodies by cloning and expression of antigen-specific antibodies and binding studies e.g. for Tetanus Toxoid or influenza vaccination.
Roshan Goswami (NVD) Immunology/Microbial Molecular Biology/ Translational Medicine Department at Research Center, GSK, Siena, Italy Learning the preparation of mRNA based synthetic vaccines and learning Cell recruitment analysis after immunization.
Abhijeet Nayak (VLA) Vakzine Project Management (VPM), Hannover, Germany Gain experience in R&D and project management (development of promising biopharmaceuticals candidates, creation of business strategies).

 

 

 

 

 

 

 

 

 

 

 

 

 

               

                     

 

 

 

 


 

Funded by the EU under the FP7 Marie Curie Action - Grant number: 316655
website built by Guus Wolswijk